HU-210
Synthetic cannabinoid / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about HU-210?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
HU-210 is a synthetic cannabinoid that was first synthesized in 1988 from (1R,5S)-myrtenol[2] by a group led by Raphael Mechoulam at the Hebrew University.[3][4][5] HU-210 is 100 to 800 times more potent than natural THC from cannabis and has an extended duration of action.[6] HU-210 has a binding affinity of 0.061 nM at CB1 and 0.52 nM at CB2 in cloned human cannabinoid receptors[7] compared to delta-9-THC of 40.7 nM at CB1. [8] HU-210 is the (–)-1,1-dimethylheptyl analog of 11-hydroxy- Δ8- tetrahydrocannabinol; in some references it is called 1,1-dimethylheptyl- 11-hydroxytetrahydrocannabinol. The abbreviation "HU" stands for Hebrew University.
Quick Facts Clinical data, Other names ...
Clinical data | |
---|---|
Other names | 1,1-Dimethylheptyl- 11-hydroxy- tetrahydrocannabinol |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H38O3 |
Molar mass | 386.576 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close